Patients Achieved Remission Within 30 Days in Cohort 1 of the Mipletamig RAINIER Dose Optimization Trial for Frontline AML Patients, Trial Enrollment ContinuesPromising Data, including a 59% Stable ...
Logan Barber turned 12 on Saturday, Feb. 8. He wanted to celebrate this milestone by going out with his family. His chosen ...
IN8bio is accelerating patient enrollment in the INB-100 program and expects to complete enrollment of the expansion cohort in 2025. The company’s FDA discussions confirmed that relapse-free survival ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback